APO Research
Talk to an analyst

APO RESEARCH · REPORT

Orthobiologics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Orthobiologics Market Outlook and Growth Opportunities 2026

21 December 2025209 pages

Choose your research edition.

Industry ResearchOrthobiologics Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal Orthobiologics Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Orthobiologics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Orthobiologics Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Orthobiologics Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Orthobiologics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Orthobiologics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Orthobiologics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Orthobiologics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Orthobiologics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Orthobiologics market include Stryker Corporation, Sanofi-Aventis (Sanofi SA), Medtronic, Zimmer Biomet Holdings, TRB Chemedica International SA, Seikagaku Corporation, SeaSpine Holdings Corporation, RTI Surgical, Inc. and Orthofix International N.V., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Orthobiologics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Orthobiologics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Orthobiologics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Orthobiologics market size, projected growth trends, production technologies, key applications, and end-use industries.

Orthobiologics Segment by Company

Stryker Corporation

Sanofi-Aventis (Sanofi SA)

Medtronic

Zimmer Biomet Holdings

TRB Chemedica International SA

Seikagaku Corporation

SeaSpine Holdings Corporation

RTI Surgical, Inc.

Orthofix International N.V.

NuVasive, Inc.

Musculoskeletal Transplant Foundation, Inc.

Ito

Heraeus Holding GmbH

Fidia Pharma USA Inc.

Djo Global, Inc.

DePuy Synthes (Johnson & Johnson)

Bioventus

Arthrex, Inc.

Anika Therapeutics, Inc.

Allosource

Orthobiologics Segment by Type

Viscosupplements

Bone Graft Substitute

Bone Growth Stimulators (BGS)

Orthobiologics Segment by Application

Hospitals

Ambulatory Surgical Centres

Orthopaedics Clinics

Orthobiologics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Orthobiologics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Orthobiologics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Orthobiologics significant trends, drivers, influence factors in global and regions.

6. To analyze Orthobiologics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orthobiologics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Orthobiologics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Orthobiologics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Orthobiologics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Orthobiologics industry.

Chapter 3: Detailed analysis of Orthobiologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Orthobiologics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Orthobiologics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Orthobiologics Industry Trends Table 2. Orthobiologics Industry Drivers Table 3. Orthobiologics Industry Opportunities and Challenges Table 4. Orthobiologics Industry Restraints Table 5. Global Orthobiologics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Orthobiologics Revenue Share by Company (2021-2026) Table 7. Global Orthobiologics Sales Volume by Company (k units) & (2021-2026) Table 8. Global Orthobiologics Sales Volume Share by Company (2021-2026) Table 9. Global Orthobiologics Average Price (US$/unit) of Company (2021-2026) Table 10. Global Orthobiologics Company Ranking, (2024-2026) & (USD Million) Table 11. Global Orthobiologics Key Company Manufacturing Base & Headquarters Table 12. Global Orthobiologics Company, Product Type & Application Table 13. Global Orthobiologics Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Orthobiologics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Viscosupplements Table 18. Significant Companies of Bone Graft Substitute Table 19. Significant Companies of Bone Growth Stimulators (BGS) Table 20. Global Orthobiologics Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Orthobiologics Sales Volume by Type (2021-2026) & (k units) Table 22. Global Orthobiologics Sales Volume by Type (2027-2032) & (k units) Table 23. Global Orthobiologics Sales Volume Share by Type (2021-2026) Table 24. Global Orthobiologics Sales Volume Share by Type (2027-2032) Table 25. Global Orthobiologics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Orthobiologics Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Orthobiologics Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Orthobiologics Sales Value Share by Type (2021-2026) Table 29. Global Orthobiologics Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospitals Table 31. Significant Companies of Ambulatory Surgical Centres Table 32. Significant Companies of Orthopaedics Clinics Table 33. Global Orthobiologics Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Orthobiologics Sales Volume by Application (2021-2026) & (k units) Table 35. Global Orthobiologics Sales Volume by Application (2027-2032) & (k units) Table 36. Global Orthobiologics Sales Volume Share by Application (2021-2026) Table 37. Global Orthobiologics Sales Volume Share by Application (2027-2032) Table 38. Global Orthobiologics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Orthobiologics Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Orthobiologics Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Orthobiologics Sales Value Share by Application (2021-2026) Table 42. Global Orthobiologics Sales Value Share by Application (2027-2032) Table 43. Global Orthobiologics Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Orthobiologics Sales by Region (2021-2026) & (k units) Table 45. Global Orthobiologics Sales Market Share by Region (2021-2026) Table 46. Global Orthobiologics Sales by Region (2027-2032) & (k units) Table 47. Global Orthobiologics Sales Market Share by Region (2027-2032) Table 48. Global Orthobiologics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Orthobiologics Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Orthobiologics Sales Value Share by Region (2021-2026) Table 51. Global Orthobiologics Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Orthobiologics Sales Value Share by Region (2027-2032) Table 53. Global Orthobiologics Market Average Price (US$/unit) by Region (2021-2026) Table 54. Global Orthobiologics Market Average Price (US$/unit) by Region (2027-2032) Table 55. Global Orthobiologics Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Orthobiologics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Orthobiologics Sales by Country (2021-2026) & (k units) Table 58. Global Orthobiologics Sales Market Share by Country (2021-2026) Table 59. Global Orthobiologics Sales by Country (2027-2032) & (k units) Table 60. Global Orthobiologics Sales Market Share by Country (2027-2032) Table 61. Global Orthobiologics Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Orthobiologics Sales Value Market Share by Country (2021-2026) Table 63. Global Orthobiologics Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Orthobiologics Sales Value Market Share by Country (2027-2032) Table 65. Stryker Corporation Company Information Table 66. Stryker Corporation Business Overview Table 67. Stryker Corporation Orthobiologics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Stryker Corporation Orthobiologics Product Portfolio Table 69. Stryker Corporation Recent Development Table 70. Sanofi-Aventis (Sanofi SA) Company Information Table 71. Sanofi-Aventis (Sanofi SA) Business Overview Table 72. Sanofi-Aventis (Sanofi SA) Orthobiologics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Sanofi-Aventis (Sanofi SA) Orthobiologics Product Portfolio Table 74. Sanofi-Aventis (Sanofi SA) Recent Development Table 75. Medtronic Company Information Table 76. Medtronic Business Overview Table 77. Medtronic Orthobiologics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Medtronic Orthobiologics Product Portfolio Table 79. Medtronic Recent Development Table 80. Zimmer Biomet Holdings Company Information Table 81. Zimmer Biomet Holdings Business Overview Table 82. Zimmer Biomet Holdings Orthobiologics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Zimmer Biomet Holdings Orthobiologics Product Portfolio Table 84. Zimmer Biomet Holdings Recent Development Table 85. TRB Chemedica International SA Company Information Table 86. TRB Chemedica International SA Business Overview Table 87. TRB Chemedica International SA Orthobiologics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. TRB Chemedica International SA Orthobiologics Product Portfolio Table 89. TRB Chemedica International SA Recent Development Table 90. Seikagaku Corporation Company Information Table 91. Seikagaku Corporation Business Overview Table 92. Seikagaku Corporation Orthobiologics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Seikagaku Corporation Orthobiologics Product Portfolio Table 94. Seikagaku Corporation Recent Development Table 95. SeaSpine Holdings Corporation Company Information Table 96. SeaSpine Holdings Corporation Business Overview Table 97. SeaSpine Holdings Corporation Orthobiologics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. SeaSpine Holdings Corporation Orthobiologics Product Portfolio Table 99. SeaSpine Holdings Corporation Recent Development Table 100. RTI Surgical, Inc. Company Information Table 101. RTI Surgical, Inc. Business Overview Table 102. RTI Surgical, Inc. Orthobiologics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. RTI Surgical, Inc. Orthobiologics Product Portfolio Table 104. RTI Surgical, Inc. Recent Development Table 105. Orthofix International N.V. Company Information Table 106. Orthofix International N.V. Business Overview Table 107. Orthofix International N.V. Orthobiologics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Orthofix International N.V. Orthobiologics Product Portfolio Table 109. Orthofix International N.V. Recent Development Table 110. NuVasive, Inc. Company Information Table 111. NuVasive, Inc. Business Overview Table 112. NuVasive, Inc. Orthobiologics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. NuVasive, Inc. Orthobiologics Product Portfolio Table 114. NuVasive, Inc. Recent Development Table 115. Musculoskeletal Transplant Foundation, Inc. Company Information Table 116. Musculoskeletal Transplant Foundation, Inc. Business Overview Table 117. Musculoskeletal Transplant Foundation, Inc. Orthobiologics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. Musculoskeletal Transplant Foundation, Inc. Orthobiologics Product Portfolio Table 119. Musculoskeletal Transplant Foundation, Inc. Recent Development Table 120. Ito Company Information Table 121. Ito Business Overview Table 122. Ito Orthobiologics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. Ito Orthobiologics Product Portfolio Table 124. Ito Recent Development Table 125. Heraeus Holding GmbH Company Information Table 126. Heraeus Holding GmbH Business Overview Table 127. Heraeus Holding GmbH Orthobiologics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 128. Heraeus Holding GmbH Orthobiologics Product Portfolio Table 129. Heraeus Holding GmbH Recent Development Table 130. Fidia Pharma USA Inc. Company Information Table 131. Fidia Pharma USA Inc. Business Overview Table 132. Fidia Pharma USA Inc. Orthobiologics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 133. Fidia Pharma USA Inc. Orthobiologics Product Portfolio Table 134. Fidia Pharma USA Inc. Recent Development Table 135. Djo Global, Inc. Company Information Table 136. Djo Global, Inc. Business Overview Table 137. Djo Global, Inc. Orthobiologics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 138. Djo Global, Inc. Orthobiologics Product Portfolio Table 139. Djo Global, Inc. Recent Development Table 140. DePuy Synthes (Johnson & Johnson) Company Information Table 141. DePuy Synthes (Johnson & Johnson) Business Overview Table 142. DePuy Synthes (Johnson & Johnson) Orthobiologics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 143. DePuy Synthes (Johnson & Johnson) Orthobiologics Product Portfolio Table 144. DePuy Synthes (Johnson & Johnson) Recent Development Table 145. Bioventus Company Information Table 146. Bioventus Business Overview Table 147. Bioventus Orthobiologics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 148. Bioventus Orthobiologics Product Portfolio Table 149. Bioventus Recent Development Table 150. Arthrex, Inc. Company Information Table 151. Arthrex, Inc. Business Overview Table 152. Arthrex, Inc. Orthobiologics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 153. Arthrex, Inc. Orthobiologics Product Portfolio Table 154. Arthrex, Inc. Recent Development Table 155. Anika Therapeutics, Inc. Company Information Table 156. Anika Therapeutics, Inc. Business Overview Table 157. Anika Therapeutics, Inc. Orthobiologics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 158. Anika Therapeutics, Inc. Orthobiologics Product Portfolio Table 159. Anika Therapeutics, Inc. Recent Development Table 160. Allosource Company Information Table 161. Allosource Business Overview Table 162. Allosource Orthobiologics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 163. Allosource Orthobiologics Product Portfolio Table 164. Allosource Recent Development Table 165. Key Raw Materials Table 166. Raw Materials Key Suppliers Table 167. Orthobiologics Distributors List Table 168. Orthobiologics Customers List Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. Orthobiologics Product Image Figure 2. Global Orthobiologics Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Orthobiologics Sales Value (2021-2032) & (US$ Million) Figure 4. Global Orthobiologics Sales (2021-2032) & (k units) Figure 5. Global Orthobiologics Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Orthobiologics Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Viscosupplements Image Figure 10. Bone Graft Substitute Image Figure 11. Bone Growth Stimulators (BGS) Image Figure 12. Global Orthobiologics Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Orthobiologics Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Orthobiologics Sales Volume Share by Type (2021-2032) Figure 15. Global Orthobiologics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Orthobiologics Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Orthobiologics Sales Value Share by Type (2021-2032) Figure 18. Hospitals Image Figure 19. Ambulatory Surgical Centres Image Figure 20. Orthopaedics Clinics Image Figure 21. Global Orthobiologics Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Orthobiologics Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Orthobiologics Sales Volume Share by Application (2021-2032) Figure 24. Global Orthobiologics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Orthobiologics Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Orthobiologics Sales Value Share by Application (2021-2032) Figure 27. Global Orthobiologics Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Orthobiologics Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Orthobiologics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Orthobiologics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Orthobiologics Sales Value (2021-2032) & (US$ Million) Figure 32. North America Orthobiologics Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Orthobiologics Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Orthobiologics Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Orthobiologics Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Orthobiologics Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Orthobiologics Sales Value (2021-2032) & (US$ Million) Figure 38. South America Orthobiologics Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Orthobiologics Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Orthobiologics Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Orthobiologics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Orthobiologics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Orthobiologics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Orthobiologics Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Orthobiologics Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Viscosupplements
  • Bone Graft Substitute
  • Bone Growth Stimulators (BGS)
Applications
  • Hospitals
  • Ambulatory Surgical Centres
  • Orthopaedics Clinics
Companies covered
  • Stryker Corporation
  • Sanofi-Aventis (Sanofi SA)
  • Medtronic
  • Zimmer Biomet Holdings
  • TRB Chemedica International SA
  • Seikagaku Corporation
  • SeaSpine Holdings Corporation
  • RTI Surgical, Inc.
  • Orthofix International N.V.
  • NuVasive, Inc.
  • Musculoskeletal Transplant Foundation, Inc.
  • Ito
  • Heraeus Holding GmbH
  • Fidia Pharma USA Inc.
  • Djo Global, Inc.
  • DePuy Synthes (Johnson & Johnson)
  • Bioventus
  • Arthrex, Inc.
  • Anika Therapeutics, Inc.
  • Allosource

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Orthobiologics Sales Value (2021-2032)
  4. 1.2.2 Global Orthobiologics Sales Volume (2021-2032)
  5. 1.2.3 Global Orthobiologics Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Orthobiologics Market Dynamics
  1. 2.1 Orthobiologics Industry Trends
  2. 2.2 Orthobiologics Industry Drivers
  3. 2.3 Orthobiologics Industry Opportunities and Challenges
  4. 2.4 Orthobiologics Industry Restraints
3 Orthobiologics Market by Company
  1. 3.1 Global Orthobiologics Company Revenue Ranking in 2025
  2. 3.2 Global Orthobiologics Revenue by Company (2021-2026)
  3. 3.3 Global Orthobiologics Sales Volume by Company (2021-2026)
  4. 3.4 Global Orthobiologics Average Price by Company (2021-2026)
  5. 3.5 Global Orthobiologics Company Ranking (2024-2026)
  6. 3.6 Global Orthobiologics Company Manufacturing Base and Headquarters
  7. 3.7 Global Orthobiologics Company Product Type and Application
  8. 3.8 Global Orthobiologics Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Orthobiologics Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Orthobiologics Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Orthobiologics Market by Type
  1. 4.1 Orthobiologics Type Introduction
  2. 4.1.1 Viscosupplements
  3. 4.1.2 Bone Graft Substitute
  4. 4.1.3 Bone Growth Stimulators (BGS)
  5. 4.2 Global Orthobiologics Sales Volume by Type
  6. 4.2.1 Global Orthobiologics Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Orthobiologics Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Orthobiologics Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Orthobiologics Sales Value by Type
  10. 4.3.1 Global Orthobiologics Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Orthobiologics Sales Value by Type (2021-2032)
  12. 4.3.3 Global Orthobiologics Sales Value Share by Type (2021-2032)
5 Orthobiologics Market by Application
  1. 5.1 Orthobiologics Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Ambulatory Surgical Centres
  4. 5.1.3 Orthopaedics Clinics
  5. 5.2 Global Orthobiologics Sales Volume by Application
  6. 5.2.1 Global Orthobiologics Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Orthobiologics Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Orthobiologics Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Orthobiologics Sales Value by Application
  10. 5.3.1 Global Orthobiologics Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Orthobiologics Sales Value by Application (2021-2032)
  12. 5.3.3 Global Orthobiologics Sales Value Share by Application (2021-2032)
6 Orthobiologics Regional Sales and Value Analysis
  1. 6.1 Global Orthobiologics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Orthobiologics Sales by Region (2021-2032)
  3. 6.2.1 Global Orthobiologics Sales by Region: 2021-2026
  4. 6.2.2 Global Orthobiologics Sales by Region (2027-2032)
  5. 6.3 Global Orthobiologics Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Orthobiologics Sales Value by Region (2021-2032)
  7. 6.4.1 Global Orthobiologics Sales Value by Region: 2021-2026
  8. 6.4.2 Global Orthobiologics Sales Value by Region (2027-2032)
  9. 6.5 Global Orthobiologics Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Orthobiologics Sales Value (2021-2032)
  12. 6.6.2 North America Orthobiologics Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Orthobiologics Sales Value (2021-2032)
  15. 6.7.2 Europe Orthobiologics Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Orthobiologics Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Orthobiologics Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Orthobiologics Sales Value (2021-2032)
  21. 6.9.2 South America Orthobiologics Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Orthobiologics Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Orthobiologics Sales Value Share by Country, 2025 VS 2032
7 Orthobiologics Country-level Sales and Value Analysis
  1. 7.1 Global Orthobiologics Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Orthobiologics Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Orthobiologics Sales by Country (2021-2032)
  4. 7.3.1 Global Orthobiologics Sales by Country (2021-2026)
  5. 7.3.2 Global Orthobiologics Sales by Country (2027-2032)
  6. 7.4 Global Orthobiologics Sales Value by Country (2021-2032)
  7. 7.4.1 Global Orthobiologics Sales Value by Country (2021-2026)
  8. 7.4.2 Global Orthobiologics Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Orthobiologics Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Orthobiologics Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Orthobiologics Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Orthobiologics Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Orthobiologics Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Orthobiologics Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Orthobiologics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Orthobiologics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Orthobiologics Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Orthobiologics Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Orthobiologics Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Orthobiologics Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Orthobiologics Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Orthobiologics Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Orthobiologics Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Orthobiologics Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Orthobiologics Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Orthobiologics Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Orthobiologics Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Orthobiologics Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Orthobiologics Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Orthobiologics Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Orthobiologics Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Orthobiologics Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Orthobiologics Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Orthobiologics Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Orthobiologics Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Orthobiologics Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Orthobiologics Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Orthobiologics Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Orthobiologics Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Orthobiologics Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Orthobiologics Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Orthobiologics Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Orthobiologics Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Orthobiologics Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Orthobiologics Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Orthobiologics Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Orthobiologics Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Orthobiologics Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Orthobiologics Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Orthobiologics Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Orthobiologics Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Orthobiologics Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Orthobiologics Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Orthobiologics Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Orthobiologics Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Orthobiologics Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Orthobiologics Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Orthobiologics Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Orthobiologics Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Orthobiologics Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Orthobiologics Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Orthobiologics Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Orthobiologics Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Orthobiologics Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Orthobiologics Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Orthobiologics Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Orthobiologics Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Orthobiologics Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Orthobiologics Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Orthobiologics Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Orthobiologics Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Orthobiologics Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Orthobiologics Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Orthobiologics Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Orthobiologics Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Orthobiologics Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Orthobiologics Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Orthobiologics Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Orthobiologics Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Orthobiologics Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Orthobiologics Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Orthobiologics Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Orthobiologics Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Orthobiologics Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Orthobiologics Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Orthobiologics Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Orthobiologics Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Orthobiologics Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Orthobiologics Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Orthobiologics Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Orthobiologics Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Orthobiologics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Stryker Corporation
  2. 8.1.1 Stryker Corporation Company Information
  3. 8.1.2 Stryker Corporation Business Overview
  4. 8.1.3 Stryker Corporation Orthobiologics Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Stryker Corporation Orthobiologics Product Portfolio
  6. 8.1.5 Stryker Corporation Recent Developments
  7. 8.2 Sanofi-Aventis (Sanofi SA)
  8. 8.2.1 Sanofi-Aventis (Sanofi SA) Company Information
  9. 8.2.2 Sanofi-Aventis (Sanofi SA) Business Overview
  10. 8.2.3 Sanofi-Aventis (Sanofi SA) Orthobiologics Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi-Aventis (Sanofi SA) Orthobiologics Product Portfolio
  12. 8.2.5 Sanofi-Aventis (Sanofi SA) Recent Developments
  13. 8.3 Medtronic
  14. 8.3.1 Medtronic Company Information
  15. 8.3.2 Medtronic Business Overview
  16. 8.3.3 Medtronic Orthobiologics Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Medtronic Orthobiologics Product Portfolio
  18. 8.3.5 Medtronic Recent Developments
  19. 8.4 Zimmer Biomet Holdings
  20. 8.4.1 Zimmer Biomet Holdings Company Information
  21. 8.4.2 Zimmer Biomet Holdings Business Overview
  22. 8.4.3 Zimmer Biomet Holdings Orthobiologics Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Zimmer Biomet Holdings Orthobiologics Product Portfolio
  24. 8.4.5 Zimmer Biomet Holdings Recent Developments
  25. 8.5 TRB Chemedica International SA
  26. 8.5.1 TRB Chemedica International SA Company Information
  27. 8.5.2 TRB Chemedica International SA Business Overview
  28. 8.5.3 TRB Chemedica International SA Orthobiologics Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 TRB Chemedica International SA Orthobiologics Product Portfolio
  30. 8.5.5 TRB Chemedica International SA Recent Developments
  31. 8.6 Seikagaku Corporation
  32. 8.6.1 Seikagaku Corporation Company Information
  33. 8.6.2 Seikagaku Corporation Business Overview
  34. 8.6.3 Seikagaku Corporation Orthobiologics Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Seikagaku Corporation Orthobiologics Product Portfolio
  36. 8.6.5 Seikagaku Corporation Recent Developments
  37. 8.7 SeaSpine Holdings Corporation
  38. 8.7.1 SeaSpine Holdings Corporation Company Information
  39. 8.7.2 SeaSpine Holdings Corporation Business Overview
  40. 8.7.3 SeaSpine Holdings Corporation Orthobiologics Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 SeaSpine Holdings Corporation Orthobiologics Product Portfolio
  42. 8.7.5 SeaSpine Holdings Corporation Recent Developments
  43. 8.8 RTI Surgical, Inc.
  44. 8.8.1 RTI Surgical, Inc. Company Information
  45. 8.8.2 RTI Surgical, Inc. Business Overview
  46. 8.8.3 RTI Surgical, Inc. Orthobiologics Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 RTI Surgical, Inc. Orthobiologics Product Portfolio
  48. 8.8.5 RTI Surgical, Inc. Recent Developments
  49. 8.9 Orthofix International N.V.
  50. 8.9.1 Orthofix International N.V. Company Information
  51. 8.9.2 Orthofix International N.V. Business Overview
  52. 8.9.3 Orthofix International N.V. Orthobiologics Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Orthofix International N.V. Orthobiologics Product Portfolio
  54. 8.9.5 Orthofix International N.V. Recent Developments
  55. 8.10 NuVasive, Inc.
  56. 8.10.1 NuVasive, Inc. Company Information
  57. 8.10.2 NuVasive, Inc. Business Overview
  58. 8.10.3 NuVasive, Inc. Orthobiologics Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 NuVasive, Inc. Orthobiologics Product Portfolio
  60. 8.10.5 NuVasive, Inc. Recent Developments
  61. 8.11 Musculoskeletal Transplant Foundation, Inc.
  62. 8.11.1 Musculoskeletal Transplant Foundation, Inc. Company Information
  63. 8.11.2 Musculoskeletal Transplant Foundation, Inc. Business Overview
  64. 8.11.3 Musculoskeletal Transplant Foundation, Inc. Orthobiologics Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Musculoskeletal Transplant Foundation, Inc. Orthobiologics Product Portfolio
  66. 8.11.5 Musculoskeletal Transplant Foundation, Inc. Recent Developments
  67. 8.12 Ito
  68. 8.12.1 Ito Company Information
  69. 8.12.2 Ito Business Overview
  70. 8.12.3 Ito Orthobiologics Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Ito Orthobiologics Product Portfolio
  72. 8.12.5 Ito Recent Developments
  73. 8.13 Heraeus Holding GmbH
  74. 8.13.1 Heraeus Holding GmbH Company Information
  75. 8.13.2 Heraeus Holding GmbH Business Overview
  76. 8.13.3 Heraeus Holding GmbH Orthobiologics Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Heraeus Holding GmbH Orthobiologics Product Portfolio
  78. 8.13.5 Heraeus Holding GmbH Recent Developments
  79. 8.14 Fidia Pharma USA Inc.
  80. 8.14.1 Fidia Pharma USA Inc. Company Information
  81. 8.14.2 Fidia Pharma USA Inc. Business Overview
  82. 8.14.3 Fidia Pharma USA Inc. Orthobiologics Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Fidia Pharma USA Inc. Orthobiologics Product Portfolio
  84. 8.14.5 Fidia Pharma USA Inc. Recent Developments
  85. 8.15 Djo Global, Inc.
  86. 8.15.1 Djo Global, Inc. Company Information
  87. 8.15.2 Djo Global, Inc. Business Overview
  88. 8.15.3 Djo Global, Inc. Orthobiologics Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Djo Global, Inc. Orthobiologics Product Portfolio
  90. 8.15.5 Djo Global, Inc. Recent Developments
  91. 8.16 DePuy Synthes (Johnson & Johnson)
  92. 8.16.1 DePuy Synthes (Johnson & Johnson) Company Information
  93. 8.16.2 DePuy Synthes (Johnson & Johnson) Business Overview
  94. 8.16.3 DePuy Synthes (Johnson & Johnson) Orthobiologics Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 DePuy Synthes (Johnson & Johnson) Orthobiologics Product Portfolio
  96. 8.16.5 DePuy Synthes (Johnson & Johnson) Recent Developments
  97. 8.17 Bioventus
  98. 8.17.1 Bioventus Company Information
  99. 8.17.2 Bioventus Business Overview
  100. 8.17.3 Bioventus Orthobiologics Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Bioventus Orthobiologics Product Portfolio
  102. 8.17.5 Bioventus Recent Developments
  103. 8.18 Arthrex, Inc.
  104. 8.18.1 Arthrex, Inc. Company Information
  105. 8.18.2 Arthrex, Inc. Business Overview
  106. 8.18.3 Arthrex, Inc. Orthobiologics Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Arthrex, Inc. Orthobiologics Product Portfolio
  108. 8.18.5 Arthrex, Inc. Recent Developments
  109. 8.19 Anika Therapeutics, Inc.
  110. 8.19.1 Anika Therapeutics, Inc. Company Information
  111. 8.19.2 Anika Therapeutics, Inc. Business Overview
  112. 8.19.3 Anika Therapeutics, Inc. Orthobiologics Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Anika Therapeutics, Inc. Orthobiologics Product Portfolio
  114. 8.19.5 Anika Therapeutics, Inc. Recent Developments
  115. 8.20 Allosource
  116. 8.20.1 Allosource Company Information
  117. 8.20.2 Allosource Business Overview
  118. 8.20.3 Allosource Orthobiologics Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Allosource Orthobiologics Product Portfolio
  120. 8.20.5 Allosource Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Orthobiologics Value Chain Analysis
  2. 9.1.1 Orthobiologics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Orthobiologics Sales Mode & Process
  6. 9.2 Orthobiologics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Orthobiologics Distributors
  9. 9.2.3 Orthobiologics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst